Navigation Links
Novavax to Present Phase I/IIa Trial Data Results in an Investor Conference Call on August 26, 2008
Date:8/21/2008

ROCKVILLE, Md., Aug. 21 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that the Company will hold an investor conference call to discuss results from the Phase I/IIa human clinical trial of Novavax's H5N1 pandemic influenza VLP vaccine candidate at 11:00 a.m. Eastern Time on August 26, 2008.

The call will be hosted by Novavax President and Chief Executive Officer Dr. Rahul Singhvi and other members of senior management, including Chief Medical Officer, Dr. Penny Heaton. A question and answer session will follow the presentation of the data. The dial-in number for the conference call is USA and Canada (866) 244 4515, International: (703) 639 1168.

A live audio webcast of the conference call will be available at http://www.novavax.com. Please connect to this website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be needed to hear the webcast. A replay of the webcast will be available for 90 days after the webcast and a replay of the conference call will also be available by telephone beginning 1pm EDT, August 26, 2008 through midnight September 2, 2008. To access the replay, dial (703) 925 2533 and enter pass code 1272626.

About Novavax, Inc.

Novavax, Inc. is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like particle (VLP) technology. The Company produces these VLP based, potent, recombinant vaccines utilizing new, and efficient manufacturing approaches. Additional information about Novavax is available at http://www.novavax.
'/>"/>

SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
2. Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial
3. Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate
4. Novavax Reports Fourth Quarter and 2007 Year-End Financial Results
5. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
6. Novavax Announces Preclinical Results for Seasonal Influenza Vaccine Program
7. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
8. Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs
9. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
10. Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome)
11. Ardea Biosciences Presents Phase 2a Antiviral Activity Data for Lead HIV Candidate, RDEA806 at XVII International AIDS Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...S,Texas,Nov.23/PRNewswire-FirstCall/-- LexiconPhar...ttop-linedatafromitsPhase2clinicalstudywith LX1031...ome(IBS)willbepresentedatGASTRO2009inLondonthiswee...vementinIBSsymptoms,willbepresentedbyDr. PhilipM.B...pment,onNovember25,2009at2:30pmlocaltimeatthesessi...
(Date:11/23/2009)...ov.23/PRNewswire/--BioTrendsResearchGroup,Inc.rele...ort,thesecondinamulti-phasesyndicatedmarketresearc...Feraheme,throughthefirstsixmonthsofproductavailabi...ationfrom50uniqueNephrologistsandqualitativeinform...Feraheme,obstaclestouse,reasonstouse,typicalpatien...
(Date:11/23/2009)...exas,Nov.23/PRNewswire-FirstCall/--WoundManagement...rowingproviderofspecialtymedicalproducts,announced...edacomprehensivemanagementbusinessupdatetoillustra... Q32009salesincreased33.5%to$102,926vs.Q32008sales...creasedto$3,327,892vs.Q32008shareholderequityof$(3...
Breaking Medicine Technology:Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3Reported Use of AMAG's Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are 'On the Verge' of Use 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Gene Linked to Inherited Kidney Disease Found 55049 1Clues to gigantism provided by family in Borneo Mountains 9659 1Clues to gigantism provided by family in Borneo Mountains 9659 2Brain and Spinal Injury Trust Fund Commission Annual Meeting and Award Ceremony 55042 1Brain and Spinal Injury Trust Fund Commission Annual Meeting and Award Ceremony 55042 2
...ovio Biomedical,Corporation (AMEX:INO), focused on... and infectious diseases and a novel,alternative t...day,that partners of the company will present new ...lasmid-based immunotherapies using,Inovio,s electr...tional Conference on DNA Vaccines in Malaga, Spain...
...swire-FirstCall/ -,MIGENIX Inc. , a clinical-stage...ake a presentation of results from a recent,hepati...l 11, 2007,press release) in a non-responder patie... being held in Washington, DC May 19-24,2007. Dr....Investigative Unit (VHIU) at the Health Sciences C...
Other Medicine Technology:Inovio Biomedical's Partners to Present New Data from Two Cancer,Immunotherapy Clinical Trials 2Inovio Biomedical's Partners to Present New Data from Two Cancer,Immunotherapy Clinical Trials 3Inovio Biomedical's Partners to Present New Data from Two Cancer,Immunotherapy Clinical Trials 4Migenix to Present Celgosivir Phase II Hepatitis C Results at,Digestive Disease Week 2007 2Migenix to Present Celgosivir Phase II Hepatitis C Results at,Digestive Disease Week 2007 3
(Date:11/23/2009)..., ClinicsContinuetoTargetIndividualsintheRecommend...ewswire-USNewswire/--TheDepartmentofHealthannounce...nclinicsatlocalStateHealthCentersinDelaware,Lancas...,Nov.25.TheH1N1vaccinewillbeadministeredforfreetoi...adpreviousaccesstothevaccine.Thedepartmentasksthat...
(Date:11/23/2009)...LAND, Ore. Low-income children who don,t access h...e long term are significantly more likely to have ...cording to a new study published in the journal P...informing the financing and delivery of quality he..., "In the current policy debates about health ins...
(Date:11/23/2009)...han three-quarters getting chemo deal with insomni...thDay News) -- Insomnia and sleep disorders affect...going chemotherapy, a rate nearly three times high...y finds. , The problem is more common in younge...rs, said University of Rochester Medical Center re...
(Date:11/23/2009)..., PartnershipswithMinorityBanksin Washington ... , S.C. IntendedtoSpurEconomicGrowthandRevitali...ewswire/--DaVita,thenation,sleadingproviderofdialy...softheAnacostiacommunityfora$1millioninvestmentinI...nminoritycommunities. ,, DaVita,sinvestmentinWa...
(Date:11/23/2009)..., $4Million Alliance ProgramSupportsFutureLeade...deAvailableat www.Allia n ceS c hol...wswire/--"Mr.President,youcancountusin.Withourcomm...proudtobeapartofEducatetoInnovate,"saidAdolphP.Fal...panicHealth,afterattendingaWhiteHousemeetingtodayw...
Breaking Medicine News(10 mins):Health News:Pennsylvania Department of Health Announces Additional H1N1 Vaccination Clinics in Delaware, Lancaster, Lehigh Counties 2Health News:Children who lack continuity with a regular health care provider miss needed services 2Health News:Children who lack continuity with a regular health care provider miss needed services 3Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 2Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 3Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 4Health News:Alliance Joins President Obama at White House in Commitment to Science, Technology, Engineering, and Math (STEM) Education 2
...ms (GPS) could help identify the places most at ri...nology to identify high-hazard 'locked zones' that...eeting in Acapulco, Mexico, held by the American G...west of Seattle. Locked zones occur where ...
...dical Center (BMC) and Boston University School of...ected with the human immunodeficiency virus (HIV)...affected by co-infection with the hepatitis C viru...edical and public health concern due to its increa...
...gle predictor of aggressive prostate cancer is an ...igen (PSA) levels, according to a new study. The ...ase, called PSA velocity, of more than 2 ng/ml/yea...ingle high-risk indicator, such as a biopsy Gleaso...
...n traffic injury, leads to neck pain, headache and... of disability and health care utilization. Altho...h, a growing body of evidence suggests that the ty... issue of Arthritis Care & Research examined wheth...
...atter, domestic violence against women continues t...Injury in Australia, a comprehensive report releas...s in the country could be attributed to domestic v...ys that child sexual abuse causes 10 per cent of t...
...ers are going for vaccination of their stock again...on is fraught with great risks, experts warn. ...f vaccines to tackle H5N1.Through culling, quarant...h, chief veterinary officer of the Food and Agricu...
Other Medicine News:Health News:Persons With HIV and Alcohol Problems Co-infected With Hepatitis C 2Health News:High Pretreatment PSA Velocity Predicts Worse Outcome 2Health News:Aggressive Treatment for Whiplash Does Not Promote Faster Recovery 2Health News:Domestic Violence in Australia Leads to Number of Suicides 2Health News:Concern Expressed Over Poor Quality Bird Flu Vaccine Used in Nigeria 2
Auszyme Monoclonal
Total Prostate Specific Antigen
...prehensive line of pregnancy tests including rapid...one-step stick and cassette formats. The Clearview... is a 25 mIU urine test in a convenient stick form...or urine specimens. Wampole PreVue offers 25 mIU s...
BioCheck hCG ELISA
Medicine Products: